When Alcohol and Metabolic Problems Team Up: Why Your Liver Faces a Double Threat
MetALD, a liver condition combining alcohol use and metabolic risk, affects 2.6% of people and progresses faster than either cause alone.
18 articles
MetALD, a liver condition combining alcohol use and metabolic risk, affects 2.6% of people and progresses faster than either cause alone.
Liver cancer often hides behind common symptoms like fatigue and weight loss, making early detection crucial for better survival outcomes.
Livmarli, a drug for rare genetic liver disease, cleared disfiguring skin growths in 64% of children and reduced high cholesterol levels.
Experimental drug ION224 shows promise as first direct treatment for deadly fatty liver disease, improving liver health in 60% of trial patients.
Date-sweetened snacks marketed as healthy alternatives may pose an underestimated risk to liver health due to their high fructose content, which can accumulate...
Pharmaceutical giants invest over $9 billion in fatty liver treatments as the condition affects millions with few current options available.
Chronic hepatitis B and metabolic liver disease now overlap in millions of people worldwide, but inconsistent diagnostic tools are leaving patients...
A new cost-effectiveness analysis shows semaglutide outperforms resmetirom for treating advanced fatty liver disease, offering better value and cardiovascular...
High liver enzymes (ALT and AST) often appear without symptoms, signaling overload from diet, stress, or dehydration.
Kupffer cells, your liver's resident immune cells, play a critical role in preventing hepatocellular carcinoma.
New CDC data shows hepatitis C infections are surging while hepatitis B progress stalls.
Even moderate regular drinking depletes the liver's protective antioxidants by up to 80%, but early intervention through lifestyle changes can reverse damage...
Cirrhosis and chronic liver diseases account for 30% of digestive disease costs globally, totaling $26.1 trillion by 2050.
Global health leaders are calling on the World Health Assembly to pass the first-ever resolution on steatotic liver disease, citing its massive human and...
Artificial intelligence is revolutionizing liver disease diagnosis, with the FDA approving the first AI tool for clinical trials.
New research reveals how gut dysbiosis fuels fatty liver progression through a gut-liver axis.
Scientists discovered that asprosin, a hormone from fat tissue, shifts from protective to harmful as fatty liver disease progresses, offering a new early...
Unexplained swelling in your abdomen or legs may signal portal hypertension, a dangerous condition where liver scarring blocks blood flow.